LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 41.68 | 21.74 | 981 | 3418 | 0.2869 | 0.6855 | MN20160310_N01 | D07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 41.68 | 21.74 | 997 | 3418 | 0.2916 | 0.6892 | MN20160310_N01 | D07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 41.68 | 21.74 | 29 | 3418 | 0.0085 | 0.0403 | MN20160310_N01 | L22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 41.68 | 21.74 | 1190 | 3418 | 0.3481 | 0.7307 | MN20160310_N01 | L22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 43.65 | 21.74 | 995 | 3754 | 0.2650 | 0.6728 | MN20160310_N01 | D07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 43.65 | 21.74 | 1012 | 3754 | 0.2696 | 0.6766 | MN20160310_N01 | D07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 43.65 | 21.74 | 30 | 3754 | 0.0080 | 0.0443 | MN20160310_N01 | L22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 43.65 | 21.74 | 1198 | 3754 | 0.3191 | 0.7151 | MN20160310_N01 | L22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 45.62 | 21.74 | 997 | 4150 | 0.2402 | 0.6568 | MN20160310_N01 | D07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 45.62 | 21.74 | 1010 | 4150 | 0.2433 | 0.6597 | MN20160310_N01 | D07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 45.62 | 21.74 | 38 | 4150 | 0.0092 | 0.0765 | MN20160310_N01 | L22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 45.62 | 21.74 | 1203 | 4150 | 0.2898 | 0.6984 | MN20160310_N01 | L22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 47.59 | 21.74 | 998 | 4492 | 0.2222 | 0.6447 | MN20160310_N01 | D07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 47.59 | 21.74 | 1008 | 4492 | 0.2244 | 0.6468 | MN20160310_N01 | D07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 47.59 | 21.74 | 33 | 4492 | 0.0073 | 0.0558 | MN20160310_N01 | L22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 47.59 | 21.74 | 1204 | 4492 | 0.2680 | 0.6853 | MN20160310_N01 | L22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 49.56 | 21.74 | 1018 | 4838 | 0.2104 | 0.6376 | MN20160310_N01 | D07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 49.56 | 21.74 | 1032 | 4838 | 0.2133 | 0.6405 | MN20160310_N01 | D07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 49.56 | 21.74 | 42 | 4838 | 0.0087 | 0.0881 | MN20160310_N01 | L22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 49.56 | 21.74 | 1212 | 4838 | 0.2505 | 0.6747 | MN20160310_N01 | L22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 51.53 | 21.74 | 1033 | 5150 | 0.2006 | 0.6315 | MN20160310_N01 | D07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 51.53 | 21.74 | 1049 | 5150 | 0.2037 | 0.6346 | MN20160310_N01 | D07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 51.53 | 21.74 | 45 | 5150 | 0.0087 | 0.0966 | MN20160310_N01 | L22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 51.53 | 21.74 | 1241 | 5150 | 0.2409 | 0.6698 | MN20160310_N01 | L22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 53.50 | 21.74 | 1049 | 5425 | 0.1933 | 0.6271 | MN20160310_N01 | D07 |